Dr. Jeffrey M. Jonas, MD, is a President, Chief Executive Officer & Director at SAGE Therapeutics, Inc.
He is on the Board of Directors at Karuna Therapeutics, Inc., Generation Bio Co., Decibel Therapeutics, Inc., SAGE Therapeutics, Inc. and Pharmaceutical Research & Manufacturers of America. Dr. Jonas was previously employed as an Independent Director by PureTech Health Plc, a President-Regenerative Medicine Division by Shire Plc /Old/, an Executive Vice President by Isis Pharmaceuticals, Inc., a Chief Medical Officer & Executive Vice President by Forest Laboratories, Inc., a Vice President-Research & Clinical Development by Upjohn Laboratories LLC, a President, Chief Executive Officer & Director by AVAX Technologies, Inc., an Independent Director by CARA Therapeutics, Inc., a Chairman, President & Chief Technology Officer by Evogen, Inc., and a President by Shire Regenerative Medicine, Inc.
He also served on the board at Swedish Orphan Biovitrum AB.
He received his undergraduate degree from Amherst College and a doctorate degree from Harvard Medical School.